$TLSA

$0.62▲ -1.6% YTD

5 SEC 13D/G filings tracked · Last updated Nov 5, 2026

Filing History

News

TLSA ▼ -1.6% - Tiziana Life Sciences Ltd

CP $0.62▲ -1.6%Nov 5, 2026 · ThinkSabio Blog

$TLSA - Tiziana to Host Investor Call with Key Opinion Leaders to Discuss Positive Phase 2a INFORM-MS Topline Results…

News

TLSA ▲ +8.9% - Tiziana Life Sciences Ltd

CP $0.86▲ +8.9%Nov 2, 2026 · ThinkSabio Blog

$TLSA - Tiziana Announces Positive Topline Results from Phase 2a INFORM-MS Trial of Intranasal Foralumab in Non-Active Secondary Progressive Multiple…

News

TLSA ▲ +1.0% - Tiziana Life Sciences Ltd

CP $1.03▲ +1.0%Oct 21, 2026 · ThinkSabio Blog

$TLSA - Tiziana Management Team to Attend the 10th Joint ACTRIMS-ECTRIMS Meeting in Toronto…

News

TLSA ▲ +2.9% - Tiziana Life Sciences Ltd

CP $1.08▲ +2.9%Oct 16, 2026 · ThinkSabio Blog

$TLSA - Tiziana Doses Last Patient in Phase 2 Trial of Intranasal Foralumab for Mild Alzheimer’s Disease…

News

TLSA ▲ +6.3% - Tiziana Life Sciences Ltd

CP $1.01▲ +6.3%Sep 30, 2026 · ThinkSabio Blog

$TLSA - Tiziana Life Sciences Files for Orphan Drug Designation with the FDA for Intranasal Foralumab for the Treatment of Multiple System Atrophy (MS…